Mirae Asset Global Etfs Holdings Ltd. Xeris Biopharma Holdings, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 82,138 shares of XERS stock, worth $688,316. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,138
Previous 83,982
2.2%
Holding current value
$688,316
Previous $461,000
16.92%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding XERS
# of Institutions
207Shares Held
89.4MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$86.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$82.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$32.1 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$31.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$30.6 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.14B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...